Skip to main content
FinSpry Logo
FinSpry
ADPT logo
ADPT
(NASDAQ)
Adaptive Biotechnologies Corporation
$14.81-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Adaptive Biotechnologies (ADPT) Stock Price & Financial Analysis

Adaptive Biotechnologies Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$13.81 - $14.89
52-Week High$20.76
52-Week Low$6.68
Open$13.81
Volume1.57M
Average Volume (3M)1.57M
Market Cap2.25B
Shares Outstanding151.72M
Price to Sales (P/S)7.90
Price to Book (P/B)10.01
EV/EBITDA-80.39
Revenue (TTM)276.98M
Net Income (TTM)-59.50M
Free Cash Flow (TTM)-48.95M
EPS (TTM)$-0.39
Profit Margin-21.48%
Operating Margin-20.62%
Return on Equity (ROE)-27.19%
Debt to Equity1.28
50-Day MA$15.64
200-Day MA$14.60
52-Week Change91.89%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Adaptive Biotechnologies

What is the current stock price for ADPT?

As of the latest trading session, ADPT stock trades at $14.81. The 52-week range is $6.68–$20.76, with a day range of $13.81–$14.89.

What is the P/E ratio for ADPT?

The P/E ratio (Price-to-Earnings) for ADPT is shown in the Key Statistics section. This valuation metric helps compare Adaptive Biotechnologies Corporation to industry peers.

Does ADPT pay dividends?

Adaptive Biotechnologies does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ADPT?

Based on 7 analysts, the consensus for ADPT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ADPT?

Adaptive Biotechnologies's market capitalization is $2.25B, classifying it as a mid-cap company. Adaptive Biotechnologies operates in the Healthcare sector within the Biotechnology industry.